Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug |
---|---|
Brand | Arovia |
Product type | Recombinant Proteins |
Product name | Recombinant Human H2AJ, N-His |
---|---|
Origin species | Human |
Expression system | Prokaryotic expression |
Molecular weight | 16.11 kDa |
Buffer | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
Form | Liquid |
Delivery condition | Dry Ice |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
Brand | Arovia |
Host species | Escherichia coli (E.coli) |
Fragment Type | Gly3-Lys129 |
Aliases /Synonyms | Histone H2A.J, H2AFJ, H2a/j, H2AJ |
Reference | ARO-P13133 |
Note | For research use only. |
Recombinant Human H2AJ is a protein that plays a crucial role in regulating gene expression and maintaining the structure of chromatin. It is a variant of the histone protein H2A, which is a key component of the nucleosome, the basic unit of chromatin. In this article, we will explore the structure, activity, and application of Recombinant Human H2AJ.
Recombinant Human H2AJ is a 14-kDa protein consisting of 128 amino acids. It has a highly conserved structure, with a central globular domain and a long N-terminal tail. The globular domain is responsible for binding to DNA and forming the nucleosome, while the N-terminal tail contains post-translational modifications that regulate gene expression.
The N-terminal tail of Recombinant Human H2AJ can undergo various post-translational modifications, including acetylation, methylation, phosphorylation, and ubiquitination. These modifications can alter the chromatin structure and regulate the accessibility of DNA to transcription factors and other regulatory proteins.
Recombinant Human H2AJ has multiple functions in the cell, including:
Aberrant expression and function of Recombinant Human H2AJ have been linked to various types of cancer. For example, overexpression of H2AJ has been observed in breast cancer, and its depletion has been shown to inhibit tumor growth in vitro. Additionally, mutations in the gene encoding H2AJ have been identified in certain types of lymphomas and leukemias.
Recombinant Human H2AJ has various applications in both research and clinical settings. Some of the most common applications include:
Although Recombinant Human H2AJ has many applications, it is
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.